Global Urology Endoscopes Market Size, Share, Forecast Report, 2020-2027

The global urology endoscopes market is estimated to grow at a CAGR of over 7% during the forecast period. Urology endoscopes are the devices utilized for the diagnosis and detection of urological disorders. These devices aid inthe treatment and detection of disorders such as percutaneous nephrolithotomy (PCNL), bladder tumors, urethral obstruction, transurethral resection of the prostate (TURP), and ureteroscopic stone removal, among others. The factors that drive the growth of the global urology endoscopes market include an increase in the number of ureteroscopy interventions performed and the prevalence of urinary disorders which demands the endoscopy devices for the treatment.



Further, according to the American Cancer Society in 2020, more than 80,000 people in the US are diagnosed with bladder cancer per year. Thus, the demand for urology endoscopes is projected to rise in the near future.In addition, advancements in the endoscopic techniques in urology such as robot-assisted endoscopes or disposable endoscopes further support the market growth during the forecast period. The supportive government initiatives such as US FDA approvals for several urological endoscopy devices, such as Uro-V, the single-use cystoscope designed and manufactured by UroViu Corp., among others are likely to drive the global urology endoscopes market during the forecast period.



However, the factor that limits the growth includes the numerous risks associated with the treatment, including internal bleeding. Lithotripsy treatment, sometimes, damages kidney due to blockage in urine flow caused by small stone particles (that are a result of the procedure) coupled with other health complications, such as high blood pressure; therefore, patients are opting for substitutes of the devices.



Segmental Outlook



The global urology endoscopes market is segmented on the basis of type and application. Based on the type, the market is segmented into resectoscopes, cystoscopes, and ureteroscopes. Further, based on the application, the market is segmented into urethral malignancies, urinary bladder malignancies, urolithiasis, and others such as glomerulonephritis.



Urolithiasis segment to hold a significant share in the market



Based on the application, urolithiasis is estimated to hold a significant share in the market during the forecast period. The growth is attributed to an increased prevalence of end-stage renal failure, which increases the demand for the urology endoscope devices. Moreover, according to the Institute for Health Metrics and Evaluation, the prevalence of urolithiasis in 2012 was around 2 million which reached up to 3 million in 2017 across the globe. Development of improved lithotripsy devices and the demand for the minimally invasive treatment methods along with the escalating prevalence of urolithiasis across the globe are some of the factors that create growth opportunities for the overall market during the forecast period.



Regional Outlook



Based on the geographic viewpoint, the urology endoscopes market is segmented into North America, Europe, Asia-Pacific and Rest of the World. North America is estimated to contribute a significant share in the global market. This is accredited to the increased prevalence of urolithiasis in the region. According to Institute for Health Metrics and Evaluation, the prevalence of urolithiasis in the US is expected to rise rapidly, the prevalence of urolithiasis in the US alone was more than 210,000 in 2012 and rise up to around 232,000 in 2017. Thus, the high prevalence leads to increased demand for the treatment options, which in turn drives the growth of the global urology endoscopes market over the forecast period.



Market player Outlook



Some of the prominent players operating in the global urology endoscopes market include Boston Scientific Corp., Medtronic Plc, CR Bard Inc., Stryker Corp., Karl Storz SE & Co. KG, Coloplast Corp., Olympus Corp., and Cook Medical Inc., among others. These players are adopting various strategies such as new product launches and approvals, mergers and acquisitions, partnerships and collaborations, to thrive in a competitive environment. For instance, in April 2018, Olympus Corp. announced to acquire the lithotripsy systems design and production technology from Cybersonics Inc. Lithotripsy systems Shock Pulse-SE and Cyber Wand engineered by Cybersonics comes under the Olympus' urology systems. Thus, this acquisition further enabled the company to offer an enhanced product portfolio along with reducingthe overall costs of treatment under the urology endoscopes devices.